Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease

AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival

(2010) Jennifer Woodard et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

(2010) O. Landgren et al.   BLOOD

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metformin: A Therapeutic Opportunity in Breast Cancer

(2010) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Adiponectin Deficiency Promotes Tumor Growth in Mice by Reducing Macrophage Infiltration

(2010) Yutong Sun et al.   PLoS One

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

(2009) O. Landgren et al.   BLOOD

Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo

(2009) S. Landskroner-Eiger et al.   CLINICAL CANCER RESEARCH

Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer

(2009) M. S. Denzel et al.   CLINICAL CANCER RESEARCH

In Vitroandin VivoEffects of Adiponectin on Bone

(2009) Garry A. Williams et al.   ENDOCRINOLOGY

Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma

(2009) Janne E. Reseland et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Adiponectin Haploinsufficiency Promotes Mammary Tumor Development in MMTV-PyVT Mice by Modulation of Phosphatase and Tensin Homolog Activities

(2009) Janice B. B. Lam et al.   PLoS One

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study

(2008) Maria Dalamaga et al.   CANCER CAUSES & CONTROL

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

(2008) Stephen J. Peterson et al.   JOURNAL OF LIPID RESEARCH

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH